Dihydroboldenone vs Testosterone Propionate
A side-by-side research comparison of Dihydroboldenone and Testosterone Propionate across mechanism, dosing, half-life, benefits, side effects and research status.
Comparison table
| Attribute | Dihydroboldenone | Testosterone Propionate |
|---|---|---|
| Full name | Dihydroboldenone (1-Testosterone / DHB) | Testosterone Propionate (Short-Ester Testosterone) |
| Category | Anabolic Steroids | Anabolic Steroids |
| Status | Not medically approved (controlled substance) | Prescription drug (controlled substance) |
| Mechanism | DHB is boldenone with the double bond reduced, giving a highly anabolic, non-aromatizing steroid that does not convert to estrogen or DHT. It has strong androgen-receptor binding and promotes dry, lean gains. | Testosterone bound to a small propionate ester, giving rapid release and a short half-life. It acts on androgen receptors identically to other testosterone forms but with faster onset and offset of blood levels. |
| Molecular weight | 288.4 Da (base) | 344.5 Da |
| Half-life | Varies by ester | ~0.8-2 days |
| Bioavailability | Intramuscular injection | Intramuscular/subcutaneous injection |
| Typical dose | Lean-gain cycles (non-medical) | Variable; frequent dosing required |
| Frequency | Per ester | Every 1-2 days |
| Route | Intramuscular injection | Intramuscular or subcutaneous injection |
Dihydroboldenone reported benefits
- Strong lean mass gains
- No estrogen conversion
- No DHT conversion
- Dry, hard appearance
Testosterone Propionate reported benefits
- Rapid onset of testosterone levels
- Fast clearance (flexible timing)
- Muscle mass and strength
- Less water retention than long esters (perceived)
Related comparisons
Research and educational reference only. Not medical advice.